A systematic review of cannabidiol dosing in clinical populations.

Sophie A MillarN L StoneZ D BellmanA S YatesT J EnglandS E O'Sullivan

Published in: British journal of clinical pharmacology (2019)

This review highlights that CBD has a potential wide range of activity in several pathologies. Pharmacokinetic studies as well as conclusive phase III trials to elucidate effective plasma concentrations within medical contexts are severely lacking and highly encouraged.

Keyphrases

phase iii
open label
clinical trial
double blind
healthcare
phase ii
placebo controlled
human health
randomized controlled trial
study protocol